BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21132576)

  • 1. Natural killer cell neoplasm: biology and pathology.
    Ham MF; Ko YH
    Int J Hematol; 2010 Dec; 92(5):681-9. PubMed ID: 21132576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
    van Vliet C; Spagnolo DV
    Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extranodal T- and NK-cell lymphomas.
    de Leval L; Feldman AL; Pileri S; Nakamura S; Gaulard P
    Virchows Arch; 2023 Jan; 482(1):245-264. PubMed ID: 36336765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders.
    Lewis NE; Zhou T; Dogan A
    Haematologica; 2023 Dec; 108(12):3261-3277. PubMed ID: 38037802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis and management of extranodal NK/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia.
    Kwong YL
    J Clin Exp Hematop; 2011; 51(1):21-8. PubMed ID: 21628857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retrospective analysis of 4 cases of the so-called blastic NK-cell lymphoma, with reference to the 2008 WHO classification of tumours of haematopoietic and lymphoid tissues].
    Zheng YY; Chen G; Zhou XG; Jin Y; Xie JL; Zhang SH; Zhang YN
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):600-5. PubMed ID: 21092587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An aggressive extranodal NK-cell lymphoma arising from indolent NK-cell lymphoproliferative disorder.
    Huang Q; Chang KL; Gaal KK; Weiss LM
    Am J Surg Pathol; 2005 Nov; 29(11):1540-3. PubMed ID: 16224224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer-cell neoplasms.
    Greer JP; Mosse CA
    Curr Hematol Malig Rep; 2009 Oct; 4(4):245-52. PubMed ID: 20425414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
    Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoproliferative disorders of natural killer cells.
    Oshimi K
    Int J Hematol; 1996 Jun; 63(4):279-90. PubMed ID: 8762811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
    Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
    Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
    Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in understanding and managing natural killer-cell malignancies.
    Oshimi K
    Br J Haematol; 2007 Nov; 139(4):532-44. PubMed ID: 17916099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell neoplasms.
    Tse E; Liang RH
    Clin Lymphoma; 2004 Dec; 5(3):197-201. PubMed ID: 15636697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
    Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
    Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
    Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
    Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State of the art in natural killer cell malignancies.
    Semenzato G; Marino F; Zambello R
    Int J Lab Hematol; 2012 Apr; 34(2):117-28. PubMed ID: 21895989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.
    Jin X; Xu Y; Zhang J; Li G; Huang D; Yang Y; He H
    Diagn Pathol; 2017 Jun; 12(1):46. PubMed ID: 28623913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
    Hue SS; Oon ML; Wang S; Tan SY; Ng SB
    Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell/natural killer cell lymphoblastic lymphoma with an unusual coexpression of B-cell antigens.
    Gloeckner-Hofmann K; Ottesen K; Schmidt S; Nizze H; Feller AC; Merz H
    Ann Hematol; 2000 Nov; 79(11):635-9. PubMed ID: 11131924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.